Literature DB >> 14995001

Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus.

K Dixit1, R Ali.   

Abstract

The role of the nitric oxide (NO) radical in systemic lupus erythematosus (SLE) pathogenesis has been investigated in the present study. The binding characteristics of SLE autoantibodies with native calf thymus DNA, native and NO-modified plasmid DNA were assessed. Binding characteristics and specificity of antibodies were analysed by direct binding and inhibition ELISA, gel retardation assay and quantitative precipitin titration. The data shows preferential binding of SLE autoantibodies to NO-modified plasmid DNA (NO-DNA) in comparison with native plasmid DNA. Inhibition ELISA reiterates the direct binding results. Gel retardation assay further substantiated the enhanced recognition of NO-DNA by anti-DNA autoantibodies. The binding affinity of modified and native plasmid DNA with one of the SLE IgGs was calculated, using the Langmuir plot. The apparent association constant for NO-plasmid DNA was found to be highest, followed by native calf thymus DNA and native plasmid DNA. The results suggest that the NO radical modification of plasmid DNA causes perturbations, resulting in the generation of neo-epitopes, and making it a potential immunogen. The DNA modified with the NO radical may be one of the factors for the induction of circulating SLE anti-DNA autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14995001     DOI: 10.1191/0961203304lu492oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

1.  Neo-epitopes on crotonaldehyde modified DNA preferably recognize circulating autoantibodies in cancer patients.

Authors:  Badar Ul Islam; Parvez Ahmad; Gulam Rabbani; Kiran Dixit; Shahid Ali Siddiqui; Asif Ali
Journal:  Tumour Biol       Date:  2015-08-29

2.  Immunochemical studies on catechol-estrogen modified plasmid: possible role in rheumatoid arthritis.

Authors:  Wahid Ali Khan; Abdullah S Assiri
Journal:  J Clin Immunol       Date:  2010-09-04       Impact factor: 8.317

Review 3.  The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates; Gary S Gilkeson
Journal:  Clin Immunol       Date:  2006-07-24       Impact factor: 3.969

Review 4.  The biology of reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 5.  Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus.

Authors:  Rizwan Ahmad; Haseeb Ahsan
Journal:  Clin Exp Med       Date:  2012-11-23       Impact factor: 3.984

6.  Increased nitration and carbonylation of proteins in MRL+/+ mice exposed to trichloroethene: potential role of protein oxidation in autoimmunity.

Authors:  Gangduo Wang; Jianling Wang; Huaxian Ma; M Firoze Khan
Journal:  Toxicol Appl Pharmacol       Date:  2009-03-28       Impact factor: 4.219

7.  Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.

Authors:  Km Neelofar; Zarina Arif; Jamal Ahmad; Khursheed Alam
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

8.  Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies.

Authors:  Wahid Ali Khan
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

9.  The Role of Microparticles in Rheumatic Diseases and their Potentials as Therapeutic Tools.

Authors:  Wen-Hai Shao
Journal:  J Mol Immunol       Date:  2016-07-19

10.  A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE.

Authors:  Asif Zaman; Zarina Arif; Kafil Akhtar; Wasif Mohammad Ali; Khursheed Alam
Journal:  PLoS One       Date:  2019-05-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.